EU-SAFETY_HEALTH_WORK-PREAMBLE
EU-SAFETY_HEALTH_WORK-PREAMBLE
Safety and Health of Workers at Work Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)
This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.
Last updated 27 September 2023. Database contains 4658 unique substances/entries.
Filter the list
|
203-767-1
|
110-43-0
|
Flam. Liq. 3; Acute Tox. 4 |
||
|
213-831-0
|
1024-57-3
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
||
|
200-962-3
|
76-44-8
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
12035-71-1
|
Carc. 1A; Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
HALOXYFOP ETHOXYETHYL EST
|
402-560-5
|
87237-48-7
|
Acute Tox. 4 |
|
|
600-130-3
|
100784-20-1
|
Repr. 1B |
||
|
TILCOM HTB
|
411-740-2
|
22411-22-9
|
Eye Dam. 1; Skin Sens. 1 |
|
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
620-427-1
|
108173-90-6
|
Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
||
|
200-002-3
|
50-01-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
||
|
GUANIDINIUMBENZOAT
|
429-820-0
|
26739-54-8
|
Acute Tox. 4 |
|
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
201-964-7
|
90-05-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
||
|
219-468-4
|
2439-99-8
|
Eye Dam. 1 |
||
|
617-243-9
|
81591-81-3
|
Acute Tox. 4 |
||
|
213-997-4
|
1071-83-6
|
Eye Dam. 1 |
||
|
206-058-5
|
298-12-4
|
Eye Dam. 1; Skin Sens. 1B |
||
|
203-474-9
|
107-22-2
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
||
|
200-240-8
|
55-63-0
|
Unst. Expl.; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
||
|
200-240-8
|
55-63-0
|
Expl. 1.1; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
||
|
203-856-5
|
111-30-8
|
Acute Tox. 2; Acute Tox. 3; STOT SE 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1A |
||
|
EW 400; GLUCOPROTAMIN
|
403-950-8
|
164907-72-6
|
Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B |
|
|
278-636-5
|
77182-82-2
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
||
|
232-589-7
|
9001-22-3
|
Resp. Sens. 1 |
||
|
-
|
-
|
Carc. 2 |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
203-377-1
|
106-24-1
|
Skin Sens. 1 |
||
|
A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30°C to 260°C (86°F to 500°F).
|
289-220-8
|
86290-81-5
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 196°C(-4°F to 384°F).
|
271-025-4
|
68514-15-8
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36.1°C to 193.3°C (97°F to 380°F).
|
271-727-0
|
68606-11-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20°C to 200°C (68°F to 392°F).
|
302-639-3
|
94114-03-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.
|
271-726-5
|
68606-10-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20°C to 120°C (-4°F to 248°F).
|
232-349-1
|
8006-61-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|
|
Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 180°C (86°F to 356°F). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.
|
302-691-7
|
94114-55-3
|
Carc. 1B |
|
|
A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45°C to 185°C (113°F to 365°F).
|
297-458-9
|
93572-29-3
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|